Intra-articular therapies for osteoarthritis

References

• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2163–2196.
   PubMed Web of Science ®Google Scholar
• Hunter DJ. Lower extremity osteoarthritis management needs a paradigm shift. Br J Sports Med. 2011;45(4):283–288.
   PubMed Web of Science ®Google Scholar
• Hunter DJ, Schofield D, Callander E. The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol. 2014;10(7):437–441.
   PubMed Web of Science ®Google Scholar
• Hunter DJ. Osteoarthritis. Best Pract Res Clin Rheumatol. 2011;25(6):801–814.
   PubMed Web of Science ®Google Scholar
• Kidd B. Mechanisms of pain in osteoarthritis. Hss J. 2012;8(1):26–28.
   PubMedGoogle Scholar
• Hunter DJ, Guermazi A, Roemer F, et al. Structural correlates of pain in joints with osteoarthritis. Osteoarthritis Cartilage. 2013;21(9):1170–1178.
   PubMed Web of Science ®Google Scholar
• Castaneda S, Roman-Blas JA, Largo R, et al. Osteoarthritis: a progressive disease with changing phenotypes. Rheumatology (Oxford). 2014;53(1):1–3.
   PubMed Web of Science ®Google Scholar
• Conaghan PG, Dickson J, Grant RL, et al. Care and management of osteoarthritis in adults: summary of NICE guidance. BMJ. 2008;336(7642):502–503.
   PubMed Web of Science ®Google Scholar
• McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363–388.
   PubMed Web of Science ®Google Scholar
• da Costa BR, Reichenbach S, Keller N, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2016;387(10033):2093–2105.
   PubMed Web of Science ®Google Scholar
• McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA. 2006;296(13):1633–1644.
   PubMed Web of Science ®Google Scholar
• Scarpignato C, Lanas A, Blandizzi C, et al. Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis–an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks. BMC Med. 2015;13:55.
   PubMed Web of Science ®Google Scholar
• Spiegel BM, Farid M, Dulai GS, et al. Comparing rates of dyspepsia with Coxibs vs NSAID+PPI: a meta-analysis. Am J Med. 2006;119(5):448e27–448e36.
   Web of Science ®Google Scholar
• Solomon DH, Rassen JA, Glynn RJ, et al. The comparative safety of analgesics in older adults with arthritis. Arch Intern Med. 2010;170(22):1968–1976.
   PubMedGoogle Scholar
• Avouac J, Gossec L, Dougados M. Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage. 2007;15(8):957–965.
   PubMed Web of Science ®Google Scholar
• Citrome L, Weiss-Citrome A. A systematic review of duloxetine for osteoarthritic pain: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed? Postgrad Med. 2012;124(1):83–93.
   PubMed Web of Science ®Google Scholar
• Myers J, Wielage RC, Han B, et al. The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis. BMC Musculoskelet Disord. 2014;15:76.
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Altman RD, April KT, et al. American college of rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465–474.
   PubMed Web of Science ®Google Scholar
• Jevsevar DS, Brown GA, Jones DL, et al. The American academy of orthopaedic surgeons evidence-based guideline on: treatment of osteoarthritis of the knee, 2nd edition. J Bone Joint Surg Am. 2013;95(20):1885–1886.
   PubMedGoogle Scholar
• Chavez-Chiang CE, Sibbitt WL Jr., Band PA, et al. The highly accurate anteriolateral portal for injecting the knee. Sports Med Arthrosc Rehabil Ther Technol. 2011;3(1):6.
   PubMedGoogle Scholar
• Telikicherla M, Kamath SU. Accuracy of needle placement into the intra-articular space of the knee in osteoarthritis patients for viscosupplementation. J Clin Diagn Res. 2016;10(2):RC15–RC17.
   PubMed Web of Science ®Google Scholar
• Hunter DJ. Viscosupplementation for osteoarthritis of the knee. N Engl J Med. 2015;372(11):1040–1047.
   PubMed Web of Science ®Google Scholar
• Hollander JL, Brown EM Jr., Jessar RA, et al. Hydrocortisone and cortisone injected into arthritic joints; comparative effects of and use of hydrocortisone as a local antiarthritic agent. J Am Med Assoc. 1951;147(17):1629–1635.
   PubMed Web of Science ®Google Scholar
• MacMahon PJ, Eustace SJ, Kavanagh EC. Injectable corticosteroid and local anesthetic preparations: a review for radiologists. Radiology. 2009;252(3):647–661.
   PubMed Web of Science ®Google Scholar
• Wright JM, Cowper JJ, Page Thomas DP, et al. The hydrolysis of cortisol 21-esters by a homogenate of inflamed rabbit synovium and by rheumatoid synovial fluid. Clin Exp Rheumatol. 1983;1(2):137–141.
   PubMed Web of Science ®Google Scholar
• Creamer P. Intra-articular corticosteroid injections in osteoarthritis: do they work and if so, how? Ann Rheum Dis. 1997;56(11):634–636.
   PubMed Web of Science ®Google Scholar
• Schacke H, Schottelius A, Docke WD, et al. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci U S A. 2004;101(1):227–232.
   PubMed Web of Science ®Google Scholar
• Johnston PC, Lansang MC, Chatterjee S, et al. Intra-articular glucocorticoid injections and their effect on hypothalamic-pituitary-adrenal (HPA)-axis function. Endocrine. 2015;48(2):410–416.
   PubMed Web of Science ®Google Scholar
• Bellamy N, Campbell J, Robinson V, et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;2:CD005328.
   PubMedGoogle Scholar
• Derendorf H, Rohdewald P, Hochhaus G, et al. HPLC determination of glucocorticoid alcohols, their phosphates and hydrocortisone in aqueous solutions and biological fluids. J Pharm Biomed Anal. 1986;4(2):197–206.
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American college of rheumatology. Arthritis Rheum. 1995;38(11):1541–1546.
   PubMed Web of Science ®Google Scholar
• Behrens F, Shepard N, Mitchell N. Alterations of rabbit articular cartilage by intra-articular injections of glucocorticoids. J Bone Joint Surg Am. 1975;57(1):70–76.
   PubMed Web of Science ®Google Scholar
• Roberts WN, Babcock EA, Breitbach SA, et al. Corticosteroid injection in rheumatoid arthritis does not increase rate of total joint arthroplasty. J Rheumatol. 1996;23(6):1001–1004.
   PubMed Web of Science ®Google Scholar
• Raynauld JP. Clinical trials: impact of intraarticular steroid injections on the progression of knee osteoarthritis. Osteoarthritis Cartilage. 1999;7(3):348–349.
   PubMed Web of Science ®Google Scholar
• Raynauld JP, Buckland-Wright C, Ward R, et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2003;48(2):370–377.
   PubMed Web of Science ®Google Scholar
• Maricar N, Callaghan MJ, Felson DT, et al. Predictors of response to intra-articular steroid injections in knee osteoarthritis–a systematic review. Rheumatology (Oxford). 2013;52(6):1022–1032.
   PubMed Web of Science ®Google Scholar
• Yavuz U, Sokucu S, Albayrak A, et al. Efficacy comparisons of the intraarticular steroidal agents in the patients with knee osteoarthritis. Rheumatol Int. 2012;32(11):3391–3396.
   PubMed Web of Science ®Google Scholar
• Lomonte AB, De Morais MG, De Carvalho LO, et al. Efficacy of triamcinolone hexacetonide versus methylprednisolone acetate intraarticular injections in knee osteoarthritis: a randomized, double-blinded, 24-week study. J Rheumatol. 2015;42(9):1677–1684.
   PubMed Web of Science ®Google Scholar
• Garg N, Perry L, Deodhar A. Intra-articular and soft tissue injections, a systematic review of relative efficacy of various corticosteroids. Clin Rheumatol. 2014;33(12):1695–1706.
   PubMed Web of Science ®Google Scholar
• Gray RG, Tenenbaum J, Gottlieb NL. Local corticosteroid injection treatment in rheumatic disorders. Semin Arthritis Rheum. 1981;10(4):231–254.
   PubMed Web of Science ®Google Scholar
• Gerwin N, Hops C, Lucke A. Intraarticular drug delivery in osteoarthritis. Adv Drug Deliv Rev. 2006;58(2):226–242.
   PubMed Web of Science ®Google Scholar
• Bannuru RR, Natov NS, Obadan IE, et al. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum. 2009;61(12):1704–1711.
   PubMed Web of Science ®Google Scholar
• Balazs EA, Watson D, Duff IF, et al. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum. 1967;10(4):357–376.
   PubMed Web of Science ®Google Scholar
• Brockmeier SF, Shaffer BS. Viscosupplementation therapy for osteoarthritis. Sports Med Arthrosc. 2006;14(3):155–162.
   PubMed Web of Science ®Google Scholar
• Conrozier T, Chevalier X. Long-term experience with hylan GF-20 in the treatment of knee osteoarthritis. Expert Opin Pharmacother. 2008;9(10):1797–1804.
   PubMed Web of Science ®Google Scholar
• Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993;39:3–9.
   PubMedGoogle Scholar
• Strauss EJ, Hart JA, Miller MD, et al. Hyaluronic acid viscosupplementation and osteoarthritis: current uses and future directions. Am J Sports Med. 2009;37(8):1636–1644.
   PubMed Web of Science ®Google Scholar
• Bagga H, Burkhardt D, Sambrook P, et al. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol. 2006;33(5):946–950.
   PubMed Web of Science ®Google Scholar
• Amiel D, Toyoguchi T, Kobayashi K, et al. Long-term effect of sodium hyaluronate (Hyalgan) on osteoarthritis progression in a rabbit model. Osteoarthritis Cartilage. 2003;11(9):636–643.
   PubMed Web of Science ®Google Scholar
• Li P, Raitcheva D, Hawes M, et al. Hylan G-F 20 maintains cartilage integrity and decreases osteophyte formation in osteoarthritis through both anabolic and anti-catabolic mechanisms. Osteoarthritis Cartilage. 2012;20(11):1336–1346.
   PubMed Web of Science ®Google Scholar
• Altman RD, Manjoo A, Fierlinger A, et al. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015;16:321.
   PubMed Web of Science ®Google Scholar
• Campo GM, Avenoso A, D’Ascola A, et al. Inhibition of hyaluronan synthesis reduced inflammatory response in mouse synovial fibroblasts subjected to collagen-induced arthritis. Arch Biochem Biophys. 2012;518(1):42–52.
   PubMed Web of Science ®Google Scholar
• Williams JM, Zhang J, Kang H, et al. The effects of hyaluronic acid on fibronectin fragment mediated cartilage chondrolysis in skeletally mature rabbits. Osteoarthritis Cartilage. 2003;11(1):44–49.
   PubMed Web of Science ®Google Scholar
• Iannitti T, Elhensheri M, Bingol AO, et al. Preliminary histopathological study of intra-articular injection of a novel highly cross-linked hyaluronic acid in a rabbit model of knee osteoarthritis. J Mol Histol. 2013;44(2):191–201.
   PubMed Web of Science ®Google Scholar
• Jubb RW, Piva S, Beinat L, et al. A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract. 2003;57(6):467–474.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hall S, Hanna F, et al. Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial. BMC Musculoskelet Disord. 2011;12:195.
   PubMed Web of Science ®Google Scholar
• Henrotin Y, Chevalier X, Deberg M, et al. Early decrease of serum biomarkers of type II collagen degradation (Coll2-1) and joint inflammation (Coll2-1 NO(2)) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis: a research study part of the Biovisco study. J Orthop Res. 2013;31(6):901–907.
   PubMed Web of Science ®Google Scholar
• Conrozier T, Balblanc JC, Richette P, et al. Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: an open-label observational prospective study. J Orthop Res. 2012;30(5):679–685.
   PubMed Web of Science ®Google Scholar
• Campbell KA, Erickson BJ, Saltzman BM, et al. Is local viscosupplementation injection clinically superior to other therapies in the treatment of osteoarthritis of the knee: a systematic review of overlapping meta-analyses. Arthroscopy. 2015;31(10):2036–45e14.
   PubMed Web of Science ®Google Scholar
• Campbell J, Bellamy N, Gee T. Differences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee. Osteoarthritis Cartilage. 2007;15(12):1424–1436.
   PubMed Web of Science ®Google Scholar
• McAlindon TE, Bannuru RR. Osteoarthritis: is viscosupplementation really so unsafe for knee OA? Nat Rev Rheumatol. 2012;8(11):635–636.
   PubMed Web of Science ®Google Scholar
• Lo GH, LaValley M, McAlindon T, et al. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA. 2003;290(23):3115–3121.
   PubMed Web of Science ®Google Scholar
• Modawal A, Ferrer M, Choi HK, et al. Hyaluronic acid injections relieve knee pain. J Fam Pract. 2005;54(9):758–767.
   PubMed Web of Science ®Google Scholar
• Bannuru RR, Natov NS, Dasi UR, et al. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis–meta-analysis. Osteoarthritis Cartilage. 2011;19(6):611–619.
   PubMed Web of Science ®Google Scholar
• Rutjes AW, Juni P, da Costa BR, et al. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med. 2012;157(3):180–191.
   PubMed Web of Science ®Google Scholar
• Johansen M, Bahrt H, Altman RD, et al. Exploring reasons for the observed inconsistent trial reports on intra-articular injections with hyaluronic acid in the treatment of osteoarthritis: meta-regression analyses of randomized trials. Semin Arthritis Rheum. 2016;46(1):34–48.
   PubMed Web of Science ®Google Scholar
• Medina JM, Thomas A, Denegar CR. Knee osteoarthritis: should your patient opt for hyaluronic acid injection? J Fam Pract. 2006;55(8):669–675.
   PubMed Web of Science ®Google Scholar
• Arrich J, Piribauer F, Mad P, et al. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ. 2005;172(8):1039–1043.
   PubMed Web of Science ®Google Scholar
• Bellamy N, Campbell J, Robinson V, et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;2:CD005321.
   PubMed Web of Science ®Google Scholar
• Wang CT, Lin J, Chang CJ, et al. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am. 2004;86-A(3):538–545.
   PubMed Web of Science ®Google Scholar
• Miller LE, Block JE. US-approved intra-articular hyaluronic acid injections are safe and effective in patients with knee osteoarthritis: systematic review and meta-analysis of randomized, saline-controlled trials. Clin Med Insights Arthritis Musculoskelet Disord. 2013;6:57–63.
   PubMedGoogle Scholar
• Berenbaum F, Grifka J, Cazzaniga S, et al. A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis. Ann Rheum Dis. 2012;71(9):1454–1460.
   PubMed Web of Science ®Google Scholar
• Divine JG, Shaffer MD. Use of viscosupplementation for knee osteoarthritis: an update. Curr Sports Med Rep. 2011;10(5):279–284.
   PubMed Web of Science ®Google Scholar
• University ECaOHaS. Three treatments for osteoarthritis of the knee: evidence shos lack of benefit. Agency for Healthcare Research and Quality Comparative Effectiveness Reviews 2009 [cited 2016 Jun 20]. Available from: http://www-ncbi-nlm-nih-gov.ezproxy1.library.usyd.edu.au/pubmedhealth/PMH0008368
   Google Scholar
• Yacyshyn EA, Matteson EL. Gout after intraarticular injection of hylan GF-20 (Synvisc). J Rheumatol. 1999;26(12):2717.
   PubMed Web of Science ®Google Scholar
• Albert C, Brocq O, Gerard D, et al. Septic knee arthritis after intra-articular hyaluronate injection. Two case reports. Joint Bone Spine. 2006;73(2):205–207.
   PubMed Web of Science ®Google Scholar
• Bannuru RR, Osani M, Vaysbrot EE, et al. Comparative safety profile of hyaluronic acid products for knee osteoarthritis: a systematic review and network meta-analysis. Osteoarthritis Cartilage. 2016. DOI:10.1016/j.joca.2016.07.010
   PubMed Web of Science ®Google Scholar
• Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18(4):476–499.
   PubMed Web of Science ®Google Scholar
• Bruyere O, Cooper C, Pelletier JP, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44(3):253–263.
   PubMed Web of Science ®Google Scholar
• Bruyere O, Cooper C, Pelletier JP, et al. A consensus statement on the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-from evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016;45(4 Suppl):S3–S11.
   PubMed Web of Science ®Google Scholar
• Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol. 2013;9(12):721–730.
   PubMed Web of Science ®Google Scholar
• Hall MP, Band PA, Meislin RJ, et al. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg. 2009;17(10):602–608.
   PubMed Web of Science ®Google Scholar
• Andia I, Sanchez M, Maffulli N. Tendon healing and platelet-rich plasma therapies. Expert Opin Biol Ther. 2010;10(10):1415–1426.
   PubMed Web of Science ®Google Scholar
• Gomez R, Villalvilla A, Largo R, et al. TLR4 signalling in osteoarthritis-finding targets for candidate DMOADs. Nat Rev Rheumatol. 2015;11(3):159–170.
   PubMed Web of Science ®Google Scholar
• Kim HA, Cho ML, Choi HY, et al. The catabolic pathway mediated by toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum. 2006;54(7):2152–2163.
   PubMed Web of Science ®Google Scholar
• Marcu KB, Otero M, Olivotto E, et al. NF-kappaB signaling: multiple angles to target OA. Curr Drug Targets. 2010;11(5):599–613.
   PubMed Web of Science ®Google Scholar
• Bendinelli P, Matteucci E, Dogliotti G, et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-kappaB inhibition via HGF. J Cell Physiol. 2010;225(3):757–766.
   PubMed Web of Science ®Google Scholar
• Laudy AB, Bakker EW, Rekers M, et al. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. Br J Sports Med. 2015;49(10):657–672.
   PubMed Web of Science ®Google Scholar
• Meheux CJ, McCulloch PC, Lintner DM, et al. Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: a systematic review. Arthroscopy. 2016;32(3):495–505.
   PubMed Web of Science ®Google Scholar
• Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27(3):158–167.
   PubMed Web of Science ®Google Scholar
• Filardo G, Kon E, Di Martino A, et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord. 2012;13:229.
   PubMed Web of Science ®Google Scholar
• Sanchez M, Fiz N, Azofra J, et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 2012;28(8):1070–1078.
   PubMed Web of Science ®Google Scholar
• Cerza F, Carni S, Carcangiu A, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med. 2012;40(12):2822–2827.
   PubMed Web of Science ®Google Scholar
• Vaquerizo V, Plasencia MA, Arribas I, et al. Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. Arthroscopy. 2013;29(10):1635–1643.
   PubMed Web of Science ®Google Scholar
• Kon E, Mandelbaum B, Buda R, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. 2011;27(11):1490–1501.
   PubMed Web of Science ®Google Scholar
• Filardo G, Kon E, Pereira Ruiz MT, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2012;20(10):2082–2091.
   PubMed Web of Science ®Google Scholar
• Say F, Gurler D, Yener K, et al. Platelet-rich plasma injection is more effective than hyaluronic acid in the treatment of knee osteoarthritis. Acta Chir Orthop Traumatol Cech. 2013;80(4):278–283.
   PubMed Web of Science ®Google Scholar
• Spakova T, Rosocha J, Lacko M, et al. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012;91(5):411–417.
   PubMed Web of Science ®Google Scholar
• Patel S, Dhillon MS, Aggarwal S, et al. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013;41(2):356–364.
   PubMed Web of Science ®Google Scholar
• Scharstuhl A, Glansbeek HL, van Beuningen HM, et al. Inhibition of endogenous TGF-beta during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol. 2002;169(1):507–514.
   PubMed Web of Science ®Google Scholar
• Shen J, Li J, Wang B, et al. Deletion of the transforming growth factor beta receptor type II gene in articular chondrocytes leads to a progressive osteoarthritis-like phenotype in mice. Arthritis Rheum. 2013;65(12):3107–3119.
   PubMed Web of Science ®Google Scholar
• Goldring MB, Berenbaum F. The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res. 2004;(427 Suppl):S37–S46.
   Google Scholar
• Sadouk MB, Pelletier JP, Tardif G, et al. Human synovial fibroblasts coexpress IL-1 receptor type I and type II mRNA. The increased level of the IL-1 receptor in osteoarthritic cells is related to an increased level of the type I receptor. Lab Invest. 1995;73(3):347–355.
   PubMed Web of Science ®Google Scholar
• Martel-Pelletier J, McCollum R, DiBattista J, et al. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function. Arthritis Rheum. 1992;35(5):530–540.
   PubMed Web of Science ®Google Scholar
• Pelletier JP, Lascau-Coman V, Jovanovic D, et al. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. J Rheumatol. 1999;26(9):2002–2014.
   PubMed Web of Science ®Google Scholar
• Santangelo KS, Nuovo GJ, Bertone AL. In vivo reduction or blockade of interleukin-1beta in primary osteoarthritis influences expression of mediators implicated in pathogenesis. Osteoarthritis Cartilage. 2012;20(12):1610–1618.
   PubMed Web of Science ®Google Scholar
• Frizziero A, Giannotti E, Oliva F, et al. Autologous conditioned serum for the treatment of osteoarthritis and other possible applications in musculoskeletal disorders. Br Med Bull. 2013;105:169–184.
   PubMed Web of Science ®Google Scholar
• Baltzer AW, Moser C, Jansen SA, et al. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage. 2009;17(2):152–160.
   PubMed Web of Science ®Google Scholar
• Auw Yang KG, Raijmakers NJ, van Arkel ER, et al. Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial. Osteoarthritis Cartilage. 2008;16(4):498–505.
   PubMed Web of Science ®Google Scholar
• Barreto A, Braun TR. A method to induce interleukin-1 receptor antagonist protein from autologous whole blood. Cytokine. 2016;81:137–141.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315–317.
   PubMed Web of Science ®Google Scholar
• Barry F, Murphy M. Mesenchymal stem cells in joint disease and repair. Nat Rev Rheumatol. 2013;9(10):584–594.
   PubMed Web of Science ®Google Scholar
• Gupta PK, Das AK, Chullikana A, et al. Mesenchymal stem cells for cartilage repair in osteoarthritis. Stem Cell Res Ther. 2012;3(4):25.
   PubMed Web of Science ®Google Scholar
• Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109(10):1292–1298.
   PubMed Web of Science ®Google Scholar
• Pers YM, Ruiz M, Noel D, et al. Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives. Osteoarthritis Cartilage. 2015;23(11):2027–2035.
   PubMed Web of Science ®Google Scholar
• van der Kraan PM, Goumans MJ, Blaney Davidson E, et al. Age-dependent alteration of TGF-beta signalling in osteoarthritis. Cell Tissue Res. 2012;347(1):257–265.
   PubMed Web of Science ®Google Scholar
• Lee CH, Cook JL, Mendelson A, et al. Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study. Lancet. 2010;376(9739):440–448.
   PubMed Web of Science ®Google Scholar
• Ruiz M, Cosenza S, Maumus M, et al. Therapeutic application of mesenchymal stem cells in osteoarthritis. Expert Opin Biol Ther. 2016;16(1):33–42.
   PubMed Web of Science ®Google Scholar
• Mrugala D, Bony C, Neves N, et al. Phenotypic and functional characterisation of ovine mesenchymal stem cells: application to a cartilage defect model. Ann Rheum Dis. 2008;67(3):288–295.
   PubMed Web of Science ®Google Scholar
• Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24(5):1294–1301.
   PubMed Web of Science ®Google Scholar
• Peng L, Jia Z, Yin X, et al. Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem Cells Dev. 2008;17(4):761–773.
   PubMed Web of Science ®Google Scholar
• Wakitani S, Imoto K, Yamamoto T, et al. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage. 2002;10(3):199–206.
   PubMed Web of Science ®Google Scholar
• Nejadnik H, Hui JH, Feng Choong EP, et al. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med. 2010;38(6):1110–1116.
   PubMed Web of Science ®Google Scholar
• Wakitani S, Okabe T, Horibe S, et al. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J Tissue Eng Regen Med. 2011;5(2):146–150.
   PubMed Web of Science ®Google Scholar
• Emadedin M, Aghdami N, Taghiyar L, et al. Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis. Arch Iran Med. 2012;15(7):422–428.
   PubMed Web of Science ®Google Scholar
• Orozco L, Munar A, Soler R, et al. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: two-year follow-up results. Transplantation. 2014;97(11):e66–e68.
   PubMed Web of Science ®Google Scholar
• Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 2012;19(6):902–907.
   PubMed Web of Science ®Google Scholar
• Osborne H, Anderson L, Burt P, et al. Australasian college of sports physicians-position statement: the place of mesenchymal stem/stromal cell therapies in sport and exercise medicine. Br J Sports Med. 2015. doi:10.1136/bjsports-2015-095711. [Epub ahead of print]
   PubMedGoogle Scholar
• Elron-Gross I, Glucksam Y, Margalit R. Liposomal dexamethasone-diclofenac combinations for local osteoarthritis treatment. Int J Pharm. 2009;376(1–2):84–91.
   PubMed Web of Science ®Google Scholar
• Palmieri B, Rottigni V, Iannitti T. Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain. Drug Des Devel Ther. 2013;7:7–12.
   PubMed Web of Science ®Google Scholar
• Petrella RJE,P, Alleyne J, Maroney M. A prospective, multi-center, randomized, double-blind feasibility study to evaluate the safety and performance of hydros joint therapy and Hydros-TA joint therapy for management of pain associated with osteoarthritis in the knee. Osteoarthritis and Cartilage. 2012;20(Supplement 1):S172–S173.
   PubMed Web of Science ®Google Scholar
• Russo F, D’Este M, Vadala G, et al. Platelet rich plasma and hyaluronic acid blend for the treatment of osteoarthritis: rheological and biological evaluation. PLoS One. 2016;11(6):e0157048.
   PubMed Web of Science ®Google Scholar
• Bodick NL,J, Willwerth C, Kumar A, et al. Safety and efficacy of FX006 in patients with osteoarthritis of the knee. Osteoarthritis and Cartilage. 2014;22(Supplement):S376–S377.
   Google Scholar
• Chandrasekhar S, Harvey AK, Hrubey PS. Intra-articular administration of interleukin-1 causes prolonged suppression of cartilage proteoglycan synthesis in rats. Matrix. 1992;12(1):1–10.
   PubMedGoogle Scholar
• Chevalier X, Giraudeau B, Conrozier T, et al. Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study. J Rheumatol. 2005;32(7):1317–1323.
   PubMed Web of Science ®Google Scholar
• Chevalier X, Goupille P, Beaulieu AD, et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2009;61(3):344–352.
   PubMed Web of Science ®Google Scholar
• Griffith DL, Keck PC, Sampath TK, et al. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily. Proc Natl Acad Sci U S A. 1996;93(2):878–883.
   PubMed Web of Science ®Google Scholar
• Elshaier AM, Hakimiyan AA, Rappoport L, et al. Effect of interleukin-1beta on osteogenic protein 1-induced signaling in adult human articular chondrocytes. Arthritis Rheum. 2009;60(1):143–154.
   PubMed Web of Science ®Google Scholar
• Hunter DJ. Pharmacologic therapy for osteoarthritis–the era of disease modification. Nat Rev Rheumatol. 2011;7(1):13–22.
   PubMed Web of Science ®Google Scholar
• Hunter DJ, Pike MC, Jonas BL, et al. Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis. BMC Musculoskelet Disord. 2010;11:232.
   PubMed Web of Science ®Google Scholar
• Moore EE, Bendele AM, Thompson DL, et al. Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartilage. 2005;13(7):623–631.
   PubMed Web of Science ®Google Scholar
• Ellman MB, An HS, Muddasani P, et al. Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasis. Gene. 2008;420(1):82–89.
   PubMed Web of Science ®Google Scholar
• Sandell LJ, Xing X, Franz C, et al. Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta. Osteoarthritis Cartilage. 2008;16(12):1560–1571.
   PubMed Web of Science ®Google Scholar
• Mastbergen SC, Saris DB, Lafeber FP. Functional articular cartilage repair: here, near, or is the best approach not yet clear? Nat Rev Rheumatol. 2013;9(5):277–290.
   PubMed Web of Science ®Google Scholar
• Lohmander LS, Hellot S, Dreher D, et al. Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 2014;66(7):1820–1831.
   PubMed Web of Science ®Google Scholar
• Song IH, Althoff CE, Hermann KG, et al. Contrast-enhanced ultrasound in monitoring the efficacy of a bradykinin receptor 2 antagonist in painful knee osteoarthritis compared with MRI. Ann Rheum Dis. 2009;68(1):75–83.
   PubMed Web of Science ®Google Scholar
• Meini S, Maggi CA. Knee osteoarthritis: a role for bradykinin? Inflamm Res. 2008;57(8):351–361.
   PubMed Web of Science ®Google Scholar
• Shimonkevitz R, Thomas G, Slone DS, et al. A diketopiperazine fragment of human serum albumin modulates T-lymphocyte cytokine production through rap1. J Trauma. 2008;64(1):35–41.
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Salottolo KM, Loose H, et al. A randomized clinical trial to evaluate two doses of an intra-articular injection of LMWF-5A in adults with pain due to osteoarthritis of the knee. PLoS One. 2014;9(2):e87910.
   PubMed Web of Science ®Google Scholar
• Ha CW, Cho JJ, Elmallah RK, et al. A multicenter, single-blind, Phase IIa clinical trial to evaluate the efficacy and safety of a cell-mediated gene therapy in degenerative knee arthritis patients. Hum Gene Ther Clin Dev. 2015;26(2):125–130.
   PubMed Web of Science ®Google Scholar
• Ha CW, Noh MJ, Choi KB, et al. Initial phase I safety of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 in degenerative arthritis patients. Cytotherapy. 2012;14(2):247–256.
   PubMed Web of Science ®Google Scholar
• Zhang W, Robertson J, Jones AC, et al. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis. 2008;67(12):1716–1723.
   PubMed Web of Science ®Google Scholar